C-terminal agrin fragment 22

There are 12 papers on C-terminal agrin fragment 22 in aging research: 3 trials and 8 observational studies in people, 1 review.

Biomarker

12 papers study it1 more mentions it16 findings

1 new paper in 30 daysSee all 13 papers on C-terminal agrin fragment 22

“Correlation analysis revealed significant correlations of plasma CAF22 with HGS, gait speed, and cumulative SPPB scores in the metformin group.”
Metformin improves skeletal muscle and physical capacity by stabilizing neuromuscular junction in older adultsArchives of gerontology and geriatrics2024doi:10.1016/j.archger.2024.105587
  • Human trial3
  • Humans8

Interventions

7

Statins

upin humans3

3 studies
  1. Statins are linked with higher C-terminal agrin fragment 22 in humans.

    “One year of statin usage was associated with lower HGS, gait speed, SPPB scores and higher SAMS scores and plasma CAF22 levels (all P < .05).”

    Humans1 yearmalesn = 76

    The improvement in muscle function following statin withdrawal might involve the repair of the neuromuscular junction

    British journal of clinical pharmacology

  2. Statins are linked with higher C-terminal agrin fragment 22 in humans (patients with CHF taking statin versus nonstatin group).

    “Further investigations revealed a significant induction of CAF22, zonulin, and CRP in patients with CHF taking statin versus nonstatin group.”

    Humanspatients with CHF taking statin versus nonstatin group

    Statin Therapy Induces Gut Leakage and Neuromuscular Disjunction in Patients With Chronic Heart Failure

    Journal of cardiovascular pharmacology

  3. Statins are linked with higher C-terminal agrin fragment 22 in COPD patients (p < 0.05).

    “Statins further reduced HGS and elevated CAF22 in COPD patients (both p < 0.05).”

    Humansin COPD patientsplasmaone yearmales

    Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications

    Respiratory medicine

More on Statins

Whey protein + vitamin D

downin humans1

1 study
  1. Whey protein + vitamin D decreases C-terminal agrin fragment 22 in patients with chronic obstructive pulmonary disease (p <0.05).

    “Whey-D also reduced plasma CAF22 levels (p <0.05), suggesting NMJ repair, but did not alter plasma NfL.”

    Human trialin patients with chronic obstructive pulmonary diseaseplasma16 weeksn = 80

    A Combination of Whey Protein and Vitamin D Reduces Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial

    Archives of medical research

More on Whey protein + vitamin D

Semaglutide

upin humans1

1 study
  1. Semaglutide increases C-terminal agrin fragment 22 in humans (compared with sitagliptin control group) (more pronounced elevation than sitagliptin group).

    “this group exhibited more pronounced elevation of plasma CAF22 and NfL levels compared to the sitagliptin group (all P < .05)”

    Human trialcompared with sitagliptin control group1 yearmalesn = 68

    Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus

    British journal of clinical pharmacology

More on Semaglutide

Statin withdrawal

downin humans1

1 study
  1. Statin withdrawal is linked with lower C-terminal agrin fragment 22 in humans.

    “Conversely, 6 months after statin withdrawal, gait speed and SPPB scores were restored with a concurrent reduction in SAMS and CAF22 levels (all P < .05).”

    Humans6 monthsmalesn = 76

    The improvement in muscle function following statin withdrawal might involve the repair of the neuromuscular junction

    British journal of clinical pharmacology

More on Statin withdrawal

Angiotensin-converting enzyme inhibitors

downin humans1

1 study
  1. Angiotensin-converting enzyme inhibitors are linked with lower C-terminal agrin fragment 22 in humans (congestive heart failure) (P < .0001).

    “The level of CAF22 was significantly lower (P < .0001) in the ACEi-treated compared to non-ACEi CHF patients.”

    Humanscongestive heart failureplasma

    Angiotensin-converting enzyme inhibitors attenuate circulating CAF22 and physical decline in congestive heart failure: Diagnostic implications of CAF22

    British journal of clinical pharmacology

More on Angiotensin-converting enzyme inhibitors

Metformin

downin humans1

1 study
  1. Metformin decreases C-terminal agrin fragment 22 in humans (compared with baseline).

    “Metformin also reduced plasma CAF22 and NfL levels when compared to baseline.”

    Human trialcompared with baseline1700 mg twice a day16 weeksmales

    Metformin improves skeletal muscle and physical capacity by stabilizing neuromuscular junction in older adults

    Archives of gerontology and geriatrics

More on Metformin

Butyrate

downin humans1

1 study
  1. Butyrate decreases C-terminal agrin fragment 22 in humans (COPD patients) (all p < 0.05).

    “Butyrate also reduced the plasma levels of zonulin, LBP, and CAF22 levels in COPD patients (all p < 0.05).”

    Human trialCOPD patientscapsuleplasma300 mg capsule a day12 weeksn = 64

    Butyrate supplementation reduces sarcopenia by repairing neuromuscular junction in patients with chronic obstructive pulmonary disease

    Respiratory medicine

More on Butyrate

Associations

4

Handgrip strength

downin humans3

3 studies
  1. C-terminal agrin fragment 22 is associated with handgrip strength in humans (treatment-related changes in MIBC patients) (r = -0.80).

    “CAF22 changes correlated with HGS (r = - 0.80) and SPPB (r = - 0.75), while NfL showed weaker but significant correlations.”

    Humanstreatment-related changes in MIBC patientsplasman = 42

    Plasma CAF22 and NfL reflect neuromuscular decline during cisplatin-based chemotherapy and radical cystectomy in muscle-invasive bladder cancer

    International journal of clinical oncology

  2. C-terminal agrin fragment 22 predicts handgrip strength in humans (at baseline (T1) in MIBC patients) (β = -0.58, p < 0.001).

    “CAF22 was significantly associated with lower HGS and SPPB at T1 (β = - 0.58 and - 0.42, p < 0.001).”

    Humansat baseline (T1) in MIBC patientsplasman = 42

    Plasma CAF22 and NfL reflect neuromuscular decline during cisplatin-based chemotherapy and radical cystectomy in muscle-invasive bladder cancer

    International journal of clinical oncology

  3. C-terminal agrin fragment 22 is associated with handgrip strength in humans (patients with CHF) (r2 = 0.34, P < 0.0001).

    “There were strong inverse correlations of CAF22 with HGS (r 2 = 0.34, P < 0.0001), short physical performance battery scores (r 2 = 0.08, P = 0.0001), and GS (r 2 = 0.143, P < 0.0001).”

    Humanspatients with CHF

    Statin Therapy Induces Gut Leakage and Neuromuscular Disjunction in Patients With Chronic Heart Failure

    Journal of cardiovascular pharmacology

  4. C-terminal agrin fragment 22 is associated with handgrip strength in patients with AD and controls (p < 0.05).

    “Plasma zonulin and CAF22 exhibited robust negative associations with HGS and relatively weak but statistically significant associations with gait speed and ASMI (all p < 0.05).”

    Humansin patients with AD and controls

    Elevated plasma zonulin and CAF22 are correlated with sarcopenia and functional dependency at various stages of Alzheimer's diseases

    Neuroscience research

Muscle-invasive bladder cancer

upin humans1

1 study
  1. Muscle-invasive bladder cancer is associated with C-terminal agrin fragment 22 in humans (before and after neoadjuvant chemotherapy and post-radical cystectomy).

    “Plasma CAF22 and NfL were significantly elevated in patients versus controls at all time points.”

    Humansbefore and after neoadjuvant chemotherapy and post-radical cystectomyplasma

    Plasma CAF22 and NfL reflect neuromuscular decline during cisplatin-based chemotherapy and radical cystectomy in muscle-invasive bladder cancer

    International journal of clinical oncology

More on Muscle-invasive bladder cancer

Congestive heart failure

upin humans1

1 study
  1. C-terminal agrin fragment 22 predicts congestive heart failure in humans (congestive heart failure) (95% CI: 0.785-0.883; P < .0001).

    “The receiver operating characteristic curve analysis revealed CAF22 as a potential diagnostic marker (95% confidence interval: 0.785-0.883; P < .0001) for CHF.”

    Humanscongestive heart failure

    Angiotensin-converting enzyme inhibitors attenuate circulating CAF22 and physical decline in congestive heart failure: Diagnostic implications of CAF22

    British journal of clinical pharmacology

More on Congestive heart failure

Cumulative short physical performance battery score

mixedin humans1

1 study
  1. C-terminal agrin fragment 22 is associated with cumulative short physical performance battery score in the metformin group.

    “Correlation analysis revealed significant correlations of plasma CAF22 with HGS, gait speed, and cumulative SPPB scores in the metformin group.”

    Human trialin the metformin group1700 mg twice a day16 weeksmales

    Metformin improves skeletal muscle and physical capacity by stabilizing neuromuscular junction in older adults

    Archives of gerontology and geriatrics

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 12 papers in 12 months

See all 13 papers on C-terminal agrin fragment 22